IDO1 and neoplasm: Furthermore, tryptophan metabolism through the kynurenine pathway suppresses anti-tumor immunity, and targeting IDO1 can enhance the efficacy of immune checkpoint inhibitors in advanced cancers (Triplett et al., 2018).